In the most recent trading session, Boston Scientific (BSX) closed at $42.68, indicating a -1.84% sh

Boston Scientific has suffered a 50% share price decline amid decelerating growth and competitive th

Stifel analyst Rick Wise maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price t

Jefferies analyst Matthew Taylor maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the

Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.07% on an annua

Jim Cramer recommends buying SOFI, and avoiding RIVN and BSX. He also says NIOBF is too speculative,

Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and

BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the pric

Canaccord Genuity analyst William Plovanic maintains Boston Scientific (NYSE:BSX) with a Buy and

Weak guidance, analyst target cuts and declining energy prices weighed on Zscaler, AutoZone, PDD Hol

Wall Street analysts change outlook on top names. For all rating changes, see analyst ratings page.

Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the

Leerink Partners analyst Mike Kratky maintains Boston Scientific (NYSE:BSX) with a Outperform and

Wall Street analysts changed outlook on RLJ and Boston Scientific, with downgrades and raised price

Barclays analyst Matt Miksic maintains Boston Scientific (NYSE:BSX) with a Overweight and lowers

Wells Fargo analyst Larry Biegelsen downgrades Boston Scientific (NYSE:BSX) from Overweight to Eq

Dow notches fresh all-time high while Nasdaq 100 drops 0.7% as chip stocks unwind. Oil sinks nearly

Boston Scientific reported positive FRACTURE trial results for its SEISMIQ 4CE coronary IVL catheter

Wall Street analysts updated ratings for top stocks. Guggenheim lowered price target for Elastic, Mo

Late-breaking data from global pivotal study achieved high rates of freedom from major adverse cardi

Baird analyst David Rescott maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers t

Boston Scientific invested $1.5 billion in MiRus and secured an option to acquire its investigationa

B of A Securities analyst Bob Hopkins maintains Boston Scientific (NYSE:BSX) with a Buy and lower

Boston Scientific Corporation (NYSE:BSX) today announced that it has entered into an accelerated sha

Boston Scientific Corporation (NYSE:BSX) today announced it has invested $1.5 billion in return for

"I don't understand how this thing could have fallen so fast," the Mad Money host said o

Jim Cramer says investors are aggressively favoring AI stocks while heavily punishing companies that

Cramer shared his thoughts on various stocks, calling Joby Aviation too risky, BillionToOne a winner

Earnings season is here and some big stocks like Tesla, AmEx, and Intel have already reported strong

Canaccord Genuity analyst William Plovanic maintains Boston Scientific (NYSE:BSX) with a Buy and

RBC Capital analyst Shagun Singh maintains Boston Scientific (NYSE:BSX) with a Outperform and low

Barclays analyst Matt Miksic maintains Boston Scientific (NYSE:BSX) with a Overweight and lowers

Evercore ISI Group analyst Vijay Kumar maintains Boston Scientific (NYSE:BSX) with a Outperform a

Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Overweight and

BSX reported positive Q1 earnings, beating estimates and maintaining strong sales growth. Analysts h

Top Wall Street analysts changed their outlook on top names. See analyst ratings page for all change

Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and

Baird analyst David Rescott maintains Boston Scientific (NYSE:BSX) with a Outperform and lowers t

Goldman Sachs analyst David Roman maintains Boston Scientific (NYSE:BSX) with a Buy and lowers th

Needham analyst Mike Matson maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the pric

Jefferies analyst Matthew Taylor maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the

Q1 2026 Earnings: Boston Scientific beats estimates with $5.20B revenue. Explore the cardiovascular

Tech stocks brushed new record highs during midday Wednesday, as a fresh wave of blockbuster corpora

U.S. stocks were higher, with the Dow Jones gaining over 350 points on Wednesday. GE Vernova shares

Barclays analyst Matt Miksic maintains Boston Scientific (NYSE:BSX) with a Overweight and lowers